XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development

Journal of Experimental Medicine

Volumn 206, Issue 10, 2009, Pages 2151-2159

  Todd, Derrick J ^a,b   McHeyzer Williams, Louise J ^c   Kowal, Czeslawa ^d,e   Lee, Ann Hwee ^a   Volpe, Bruce T ^f   Diamond, Betty ^d,e   McHeyzer Williams, Michael G ^c   Glimcher, Laurie H ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; SYNDECAN 1; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTORS; SDC1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CONTROLLED STUDY; LUPUS VULGARIS; MEMORY CELL; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRESS; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; CELL CULTURE; CYTOLOGY; IMMUNOLOGICAL MEMORY; MOUSE MUTANT; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEW ZEALAND BLACK MOUSE; PHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; IMMUNOLOGIC MEMORY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MICE, INBRED NZB; MICE, KNOCKOUT; PLASMA CELLS; SYNDECAN-1; TRANSCRIPTION FACTORS;

EID: 70350452319     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090738     Document Type: Article

References (41)

1. Angelin-Duclos, C., G. Cattoretti, K.I. Lin, and K. Calame. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165:5462-5471.
2. Baldridge, J.R., and R.T. Crane. 1999. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines. Methods. 19:103-107. doi:10.1006/meth.1999.0834
3. Brewer, J.W., and J.A. Diehl. 2000. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc. Natl. Acad. Sci. USA. 97:12625-12630. doi:10.1073/pnas.220247197
4. Calame, K.L., K.-I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:205-230. doi:10.1146/annurev.immunol.21.120601.141138
5. Calfon, M., H. Zeng, F. Urano, J.H. Till, S.R. Hubbard, H.P. Harding, S.G. Clark, and D. Ron. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 415:92-96. doi:10.1038/415092a
6. DeGiorgio, L.A., K.N. Konstantinov, S.C. Lee, J.A. Hardin, B.T. Volpe, and B. Diamond. 2001. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7:1189-1193. doi:10.1038/nm1101-1189
7. Hardy, R.R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595-621. doi:10.1146/annurev.immunol.19.1.595
8. Hetz, C., A.H. Lee, D. Gonzalez-Romero, P. Thielen, J. Castilla, C. Soto, and L.H. Glimcher. 2008. Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc. Natl. Acad. Sci. USA. 105:757-762. doi:10.1073/pnas.0711094105
9. Hu, C.C., S.K. Dougan, A.M. McGehee, J.C. Love, and H.L. Ploegh. 2009. XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells. EMBO J. 28:1624-1636. doi:10.1038/emboj.2009.117
10. Iwakoshi, N.N., A.H. Lee, P. Vallabhajosyula, K.L. Otipoby, K. Rajewsky, and L.H. Glimcher. 2003. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4:321-329. doi:10.1038/ni907
11. Iwakoshi, N.N., M. Pypaert, and L.H. Glimcher. 2007. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J. Exp. Med. 204:2267-2275. doi:10.1084/jem.20070525
12. Kallies, A., J. Hasbold, K. Fairfax, C. Pridans, D. Emslie, B.S. McKenzie, A.M. Lew, L.M. Corcoran, P.D. Hodgkin, D.M. Tarlinton, and S.L. Nutt. 2007. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. Immunity. 26:555-566. doi:10.1016/j.immuni. 2007.04.007
13. Kaser, A., A.H. Lee, A. Franke, J.N. Glickman, S. Zeissig, H. Tilg, E.E. Nieuwenhuis, D.E. Higgins, S. Schreiber, L.H. Glimcher, and R.S. Blumberg. 2008. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 134:743-756. doi:10.1016/j.cell. 2008.07.021
14. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7:773-782. doi:10.1038/ni1357
15. Kowal, C., L.A. DeGiorgio, T. Nakaoka, H. Hetherington, P.T. Huerta, B. Diamond, and B.T. Volpe. 2004. Cognition and immunity; antibody impairs memory. Immunity. 21:179-188. doi:10.1016/ j.immuni.2004.07.011
16. Kowal, C., L.A. Degiorgio, J.Y. Lee, M.A. Edgar, P.T. Huerta, B.T. Volpe, and B. Diamond. 2006. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA. 103:19854-19859. doi:10.1073/pnas.0608397104
17. Lalor, P.A., G.J.V. Nossal, R.D. Sanderson, and M.G. McHeyzer-Williams. 1992. Functional and molecular characterization of single, (4-hydroxy-3- nitrophenyl)acetyl (NP)-specific, IgG1+ B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP. Eur. J. Immunol. 22:3001-3011. doi:10.1002/eji.1830221136
18. Lee, K., W. Tirasophon, X. Shen, M. Michalak, R. Prywes, T. Okada, H. Yoshida, K. Mori, and R.J. Kaufman. 2002. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16:452-466. doi:10.1101/gad.964702
19. Lee, A.H., N.N. Iwakoshi, K.C. Anderson, and L.H. Glimcher. 2003. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc. Natl. Acad. Sci. USA. 100:9946-9951. doi:10.1073/pnas.1334037100
20. Lee, A.H., G.C. Chu, N.N. Iwakoshi, and L.H. Glimcher. 2005. XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands. EMBO J. 24:4368-4380. doi:10.1038/sj.emboj.7600903
21. Lee, A.-H., E.F. Scapa, D.E. Cohen, and L.H. Glimcher. 2008. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science. 320: 1492-1496. doi:10.1126/science.1158042
22. Liebersbach, B.F., and R.D. Sanderson. 1994. Expression of syndecan-1 inhibits cell invasion into type I collagen. J. Biol. Chem. 269:20013-20019.
23. McHeyzer-Williams, L.J., and M.G. McHeyzer-Williams. 2005. Antigenspecific memory B cell development. Annu. Rev. Immunol. 23:487-513. doi:10.1146/annurev.immunol.23.021704.115732
24. McHeyzer-Williams, M.G., M.J. McLean, P.A. Lalor, and G.J. Nossal. 1993. Antigen-driven B cell differentiation in vivo. J. Exp. Med. 178:295-307. doi:10.1084/jem.178.1.295
25. McHeyzer-Williams, L.J., M. Cool, and M.G. McHeyzer-Williams. 2000. Antigen-specific B cell memory: expression and replenishment of a novel b220(-) memory b cell compartment. J. Exp. Med. 191:1149-1166. doi:10.1084/jem.191.7.1149
26. Neubert, K., S. Meister, K. Moser, F. Weisel, D. Maseda, K. Amann, C. Wiethe, T.H. Winkler, J.R. Kalden, R.A. Manz, and R.E. Voll. 2008. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat. Med. 14:748-755. doi:10.1038/nm1763
27. Obeng, E.A., L.M. Carlson, D.M. Gutman, W.J. Harrington Jr., K.P. Lee, and L.H. Boise. 2006. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 107:4907-4916. doi:10.1182/blood-2005-08-3531
28. Putterman, C., and B. Diamond. 1998. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 188:29-38. doi:10.1084/jem.188.1.29
29. Reimold, A.M., N.N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E.M. Gravallese, D. Friend, M.J. Grusby, F. Alt, and L.H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature. 412:300-307. doi:10.1038/35085509
30. Rickert, R.C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1317-1318. doi:10.1093/nar/25.6.1317
31. Ridley, R.C., H. Xiao, H. Hata, J. Woodliff, J. Epstein, and R.D. Sanderson. 1993. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood. 81:767-774.
32. Sanderson, R.D., and M. Børset. 2002. Syndecan-1 in B lymphoid malignancies. Ann. Hematol. 81:125-135. doi:10.1007/s00277-002-0437-8
33. Sanderson, R.D., and Y. Yang. 2008. Syndecan-1: a dynamic regulator of the myeloma microenvironment. Clin. Exp. Metastasis. 25:149-159. doi:10.1007/s10585-007-9125-3
34. Sanderson, R.D., P. Lalor, and M. Bernfield. 1989. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1:27-35.
35. Shaffer, A.L., M. Shapiro-Shelef, N.N. Iwakoshi, A.H. Lee, S.B. Qian, H. Zhao, X. Yu, L. Yang, B.K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity. 21:81-93. doi:10.1016/j.immuni.2004.06.010
36. Shapiro-Shelef, M., K.I. Lin, L.J. McHeyzer-Williams, J. Liao, M.G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity. 19:607-620. doi:10.1016/S1074-7613(03)00267-X
37. Stanley, M.J., B.F. Liebersbach, W. Liu, D.J. Anhalt, and R.D. Sanderson. 1995. Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J. Biol. Chem. 270:5077-5083.
38. Todd, D.J., A.H. Lee, and L.H. Glimcher. 2008. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat. Rev. Immunol. 8:663-674. doi:10.1038/nri2359
39. Yoshida, H., T. Matsui, A. Yamamoto, T. Okada, and K. Mori. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 107:881-891. doi:10.1016/S0092-8674(01)00611-0
40. Zhou, L.J., D.C. Ord, A.L. Hughes, and T.F. Tedder. 1991. Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain. J. Immunol. 147:1424-1432.
41. Zinszner, H., M. Kuroda, X. Wang, N. Batchvarova, R.T. Lightfoot, H. Remotti, J.L. Stevens, and D. Ron. 1998. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12:982-995. doi:10.1101/gad.12.7.982